Literature DB >> 32530116

What the thyroid cancer patient wants to know: ThyCa survey by the American Head and Neck Society Endocrine Surgery Section.

Vaninder K Dhillon1, Amanda Silver Karcioglu2, Gary Bloom3, Gregory Randolph4, Miriam Lango5.   

Abstract

OBJECTIVE: To survey a large cohort of thyroid cancer survivors from ThyCa on information needs and expectations of their treatment to better understand the pretreatment counseling, information, and support needs of this population.
METHODS: Anonymous survey of thyroid cancer survivors.
RESULTS: One thousand one hundred twenty-four patients with thyroid cancer participated in the survey. Three hundred sixty-two (37.44%) reported not having had a full understanding of their treatment plan and 407 (46.41%) reported that their thyroid cancer treatment did not conform to expectations. Patients diagnosed at younger ages were significantly more likely to report inadequate understanding of the treatment, failure of treatment to meet expectations, and call for greater attention to psychological well-being. Older patients were more likely to report unexpected effects on speech and swallowing. Regardless of age, patients most frequently called for greater attention to management of energy levels (endorsed by 61% of respondents), psychological well-being (50%), and weight changes (48%).
CONCLUSIONS: Improvements are needed in age-specific communication of thyroid cancer diagnosis and treatment.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  AHNS; information needs; survey; survivorship; thyroid cancer

Mesh:

Year:  2020        PMID: 32530116     DOI: 10.1002/hed.26185

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Long-Term Quality of Life (5-15 Years Post-Thyroidectomy) of Thyroid Carcinoma Patients in Two Tertiary Care Hospitals.

Authors:  Mohammed Yousef Alyousef; Mohammed Khaled Ghandour; Mohammed Al-Mohawes; Mosaad Alnwaisir; Tahera Islam; Khalid Al Qahtani
Journal:  Cureus       Date:  2022-02-08

Review 2.  Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

Authors:  Dana M Hartl; Joanne Guerlain; Ingrid Breuskin; Julien Hadoux; Eric Baudin; Abir Al Ghuzlan; Marie Terroir-Cassou-Mounat; Livia Lamartina; Sophie Leboulleux
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.